Lucy Day - Net Worth and Insider Trading
Lucy Day Net Worth
The estimated net worth of Lucy Day is at least $42,471 dollars as of 2025-01-09. Lucy Day is the CFO of AN2 Therapeutics Inc and owns about 32,670 shares of AN2 Therapeutics Inc (ANTX) stock worth over $42,471. Details can be seen in Lucy Day's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lucy Day has not made any transactions after 2025-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lucy Day
Lucy Day Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lucy Day owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Lucy Day’s form 4 insider trades.
Insider Ownership Summary of Lucy Day
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2025-01-03 | Chief Financial Officer |
Lucy Day Latest Holdings Summary
Lucy Day currently owns a total of 1 stock. Lucy Day owns 32,670 shares of AN2 Therapeutics Inc (ANTX) as of January 3, 2025, with a value of $42,471.
Latest Holdings of Lucy Day
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2025-01-03 | 32,670 | 1.30 | 42,471 |
Holding Weightings of Lucy Day
Lucy Day Form 4 Trading Tracker
According to the SEC Form 4 filings, Lucy Day has made a total of 1 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AN2 Therapeutics Inc is the sale of 2,957 shares on January 3, 2025, which brought Lucy Day around $3,962.
Insider Trading History of Lucy Day
- 1
Lucy Day Trading Performance
Lucy Day Ownership Network
Lucy Day Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Lucy Day is the Chief Financial Officer of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , See Remarks Joshua M Eizen , and director & Chief Executive Officer Eric Easom .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Lucy Day made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , a net sale of 223,880 shares made by Kabeer Aziz , and a net purchase of 329,906 shares made by Robin Shane Readnour .
In summary, during the past 3 months, insiders sold 17,606 shares of AN2 Therapeutics Inc (ANTX) in total and bought 412,000 shares, with a net purchase of 394,394 shares. During the past 18 months, 4,108,331 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,689,778 shares were bought by its insiders, resulting in a net sale of 418,553 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Lucy Day Mailing Address
Above is the net worth, insider trading, and ownership report for Lucy Day. You might contact Lucy Day via mailing address: 2032 Middlefield Road, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
